J&J Unit Will Have April 2025 Trial in Cardiac Catheter Suit (1)

Johnson & Johnson unit Biosense Webster Inc. will face a trial in April 2025 over claims it monopolizes the nationwide market for heart-mapping catheters.

Judge James V. Selna of the US District Court for the Central District of California set the trial to begin April 29, 2025, according to a filing Wednesday.

Biosense faces antitrust claims before a jury after the US Court of Appeals for the Ninth Circuit ruled in January that Selna was wrong to grant summary judgment to Biosense.

The upcoming trial adds to legal woes for J&J, which this year agreed to pay about $700 million ...